Skip to main content
. 2022 Apr 28;13:829153. doi: 10.3389/fendo.2022.829153

Table 4.

The ART characteristics and outcomes in BPES patients with different types of FOXL2 mutations.

Group Patient ID Cycle Gn starting dosage (IU) Gn duration (days) Total dosage of Gn (IU) E2 on trigger day (pg/mL) No. of follicles >14mm on trigger day No. of retrieved oocytes No. of metaphase II oocytes No. of fertilized oocytes No. of day 3 good-quality embryos No. of good-quality blastocysts No. of good-quality embryos
A #1 1 200 18 5250 2301.0 6 3 0 2 0 1 1
#2 1 200 16 4525 3082.0 9 6 0 0 0 0 0
2 225 17 5315 1473.0 5 4 3 2 0 1 1
3 300 14 4575 739.0 1 1 1 0 0 0 0
B #3 1 Cancelled cycle due to POR
#4 1 Cancelled cycle due to POR
#5 1 300 9 2700 856.2 4 0 0 0 0 0 0
2 225 11 2925 600.0 2 3 3 2 2 0 2
3 Cancelled cycle due to POR
#6 0 Preparing for ART treatment currently
#7 1 Cancelled cycle due to POR
2 Cancelled cycle due to POR
3 Cancelled cycle due to POR
C #8 0 Egg donation
#9 0 Egg donation
D #10 1 275 18 6300 533 2 1 0 0 0 0 0
#11 0 Cancelled cycle due to POR
#12 1 300 10 4350 1011.0 1 3 3 3 0 0 0
2 150 10 2250 1692.0 4 5 4 2 1 2 2
E #13 0 Preparing for ART treatment currently
#14 1 225 14 3750 3623.0 13 3 0 0 0 0 0
#15 1 200 23 8250 399.4 1 0 0 0 0 0 0
#16 1 150 21 8925 2334.0 10 4 3 3 0 0 0
#17 0 Egg donation